L-Aspartic acid,L-leucyl-L-prolyl-L-phenylalanyl-L-phenylalanyl-|L-Asparticacid, N-[N-[N-(1-L-leucyl-L-prolyl)-L-phenylalanyl]-L-phenylalanyl]-; 11: PN:WO03050139 SEQID: 16 claimed protein; 148: PN: US20060062797 SEQID: 160unclaimed sequence; 15: PN: US20050014193 SEQID: 15 unclaimed sequence; 15: PN:WO02064734 SEQID: 15 claimed protein; 18: PN: US6462171 SEQID: 18 claimedprotein; 1: PN: WO0134631 PAGE: 34 claimed protein; 22: PN: US6472140 SEQID: 22unclaimed sequence; 25: PN: WO0046246 SEQID: 22 claimed sequence; 2: PN:WO0134631 PAGE: 34 claimed protein; 3: PN: WO2004005920 SEQID: 3 claimedprotein; 4: PN: WO02064619 SEQID: 4 claimed protein; 52: PN: US20050244334SEQID: 52 unclaimed sequence; 5: PN: JP2005239629 SEQID: 5 claimed protein; 5:PN: WO03045128 SEQID: 14 unclaimed sequence; 8: PN: US7276483 SEQID: 41unclaimed sequence; 90: PN: US20090253637 SEQID: 7 unclaimed sequence; 9: PN:WO0190182 SEQID: 14 unclaimed sequence; IAb5 CAS:#182912-74-9

Home >> Antineoplastic Drug >> L-Aspartic acid,L-leucyl-L-prolyl-L-phenylalanyl-L-phenylalanyl-

Product Name: L-Aspartic acid,L-leucyl-L-prolyl-L-phenylalanyl-L-phenylalanyl-
Synonyms: L-Asparticacid, N-[N-[N-(1-L-leucyl-L-prolyl)-L-phenylalanyl]-L-phenylalanyl]-; 11: PN:WO03050139 SEQID: 16 claimed protein; 148: PN: US20060062797 SEQID: 160unclaimed sequence; 15: PN: US20050014193 SEQID: 15 unclaimed sequence; 15: PN:WO02064734 SEQID: 15 claimed protein; 18: PN: US6462171 SEQID: 18 claimedprotein; 1: PN: WO0134631 PAGE: 34 claimed protein; 22: PN: US6472140 SEQID: 22unclaimed sequence; 25: PN: WO0046246 SEQID: 22 claimed sequence; 2: PN:WO0134631 PAGE: 34 claimed protein; 3: PN: WO2004005920 SEQID: 3 claimedprotein; 4: PN: WO02064619 SEQID: 4 claimed protein; 52: PN: US20050244334SEQID: 52 unclaimed sequence; 5: PN: JP2005239629 SEQID: 5 claimed protein; 5:PN: WO03045128 SEQID: 14 unclaimed sequence; 8: PN: US7276483 SEQID: 41unclaimed sequence; 90: PN: US20090253637 SEQID: 7 unclaimed sequence; 9: PN:WO0190182 SEQID: 14 unclaimed sequence; IAb5
CAS No.: 182912-74-9
Molecular Formula: C33H43 N5 O8
Molecular Weight : 637.72
Specification :
Place of Origin: China
Appearance :

CAS Number:
182912-74-9
Name:
L-Aspartic acid,L-leucyl-L-prolyl-L-phenylalanyl-L-phenylalanyl-
Formula:
C33H43 N5 O8
Molecular Structure:
Synonyms:
L-Asparticacid, N-[N-[N-(1-L-leucyl-L-prolyl)-L-phenylalanyl]-L-phenylalanyl]-; 11: PN:WO03050139 SEQID: 16 claimed protein; 148: PN: US20060062797 SEQID: 160unclaimed sequence; 15: PN: US20050014193 SEQID: 15 unclaimed sequence; 15: PN:WO02064734 SEQID: 15 claimed protein; 18: PN: US6462171 SEQID: 18 claimedprotein; 1: PN: WO0134631 PAGE: 34 claimed protein; 22: PN: US6472140 SEQID: 22unclaimed sequence; 25: PN: WO0046246 SEQID: 22 claimed sequence; 2: PN:WO0134631 PAGE: 34 claimed protein; 3: PN: WO2004005920 SEQID: 3 claimedprotein; 4: PN: WO02064619 SEQID: 4 claimed protein; 52: PN: US20050244334SEQID: 52 unclaimed sequence; 5: PN: JP2005239629 SEQID: 5 claimed protein; 5:PN: WO03045128 SEQID: 14 unclaimed sequence; 8: PN: US7276483 SEQID: 41unclaimed sequence; 90: PN: US20090253637 SEQID: 7 unclaimed sequence; 9: PN:WO0190182 SEQID: 14 unclaimed sequence; IAb5
Molecular Weight:
637.72
Safety:
Safety Statements 22-24/25
WGK Germany 3
Details

( Your Information is an important part of our business,and we will not share or sell any of it to anyone.)


Your Name:
Email:
Product:	L-Aspartic acid,L-leucyl-L-prolyl-L-phenylalanyl-L-phenylalanyl-
Message:

Products

Safety Statements	22-24/25
WGK Germany	3